CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 16,000 shares at $22.00 ($352,061)
- 144 Insider Sale of Securities
- 4 Open-market sale President & CEO sold 35,000 shares at $21.45 ($750,750)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 20,786 shares at $20.00 ($415,720)
- 4 Open-market sale President & CEO sold 155,000 shares at $20.45 ($3,169,766)
- 4 Open-market sale Chief Operating Officer sold 12,500 shares at $20.00 ($250,000)
- 4 Open-market sale Chief Financial Officer sold 7,500 shares at $20.00 ($150,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market sale President & CEO sold 79,336 shares at $18.45 ($1,463,749)
- 4 Open-market sale Chief Financial Officer sold 97,839 shares at an average $18.00 ($1,761,310)
Page 12 of 33 · 652 filings